Moreover, decreased expression of H1.3 is associated with a bad prognosis in acute myeloid leukemia patients with mutations in NPM1, while mutations in several RD subtypes are recurrent in B-cell lymphomas [16,44]. The gene discussed is NPM1; the disease is acute myeloid leukemia.